257 related articles for article (PubMed ID: 18024375)
1. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.
Locatelli F; Zecca M; Pession A; Morreale G; Longoni D; Di Bartolomeo P; Porta F; Fagioli F; Nobili B; Bernardo ME; Messina C;
Haematologica; 2007 Oct; 92(10):1381-8. PubMed ID: 18024375
[TBL] [Abstract][Full Text] [Related]
2. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation.
Baker JM; Lewis VA; Fernandez CV; Duval M; Crooks BN; Yuille K; Freedman MH; Doyle JJ; Dror Y
Pediatr Blood Cancer; 2009 May; 52(5):683-5. PubMed ID: 19156855
[TBL] [Abstract][Full Text] [Related]
4. Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation.
Rossi G; Giorgiani G; Comoli P; Nobili B; Salvaneschi L; De Stefano P; Maccario R; Locatelli F
Bone Marrow Transplant; 2003 Mar; 31(6):437-40. PubMed ID: 12665837
[TBL] [Abstract][Full Text] [Related]
5. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
Zecca M; Strocchio L; Pagliara D; Comoli P; Bertaina A; Giorgiani G; Perotti C; Corbella F; Brescia L; Locatelli F
Biol Blood Marrow Transplant; 2014 Apr; 20(4):571-6. PubMed ID: 24462983
[TBL] [Abstract][Full Text] [Related]
6. Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey.
Kuşkonmaz B; Ünal Ş; Bayhan T; Aytaç Eyüboğlu S; Tavil B; Çetin M; Gümrük F; Uçkan Çetinkaya D
Pediatr Blood Cancer; 2016 Apr; 63(4):695-700. PubMed ID: 26703084
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
Chaudhury S; Auerbach AD; Kernan NA; Small TN; Prockop SE; Scaradavou A; Heller G; Wolden S; O'Reilly RJ; Boulad F
Br J Haematol; 2008 Mar; 140(6):644-55. PubMed ID: 18302713
[TBL] [Abstract][Full Text] [Related]
8. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
9. Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
Yanagisawa R; Nakazawa Y; Sakashita K; Tanaka M; Shikama N; Kamijo T; Shiohara M; Koike K
Pediatr Transplant; 2009 Sep; 13(6):737-45. PubMed ID: 19207225
[TBL] [Abstract][Full Text] [Related]
10. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
Gluckman E; Rocha V; Ionescu I; Bierings M; Harris RE; Wagner J; Kurtzberg J; Champagne MA; Bonfim C; Bittencourt M; Darbyshire P; Fernandez MN; Locatelli F; Pasquini R;
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1073-82. PubMed ID: 17697970
[TBL] [Abstract][Full Text] [Related]
11. CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia.
Balci YI; Akdemir Y; Gumruk F; Cetin M; Arpaci F; Uckan D
Pediatr Blood Cancer; 2008 May; 50(5):1065-7. PubMed ID: 18000858
[TBL] [Abstract][Full Text] [Related]
12. The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors.
Shaw BE; Russell NH; Devereux S; Das-Gupta E; Mackinnon S; Madrigal JA; Pagliuca A; Mufti GJ; Byrne JL
Haematologica; 2005 Nov; 90(11):1562-9. PubMed ID: 16266905
[TBL] [Abstract][Full Text] [Related]
13. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
14. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.
Vlachos A; Federman N; Reyes-Haley C; Abramson J; Lipton JM
Bone Marrow Transplant; 2001 Feb; 27(4):381-6. PubMed ID: 11313667
[TBL] [Abstract][Full Text] [Related]
17. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.
Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY
Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956
[TBL] [Abstract][Full Text] [Related]
18. The changing role of stem cell transplantation in childhood.
Locatelli F; Giorgiani G; Di-Cesare-Merlone A; Merli P; Sparta V; Moretta F
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S3-7. PubMed ID: 18545240
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Ringdén O; Remberger M; Svenberg P; Svahn BM; Dahllöf G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Bone Marrow Transplant; 2007 Apr; 39(7):383-8. PubMed ID: 17310137
[TBL] [Abstract][Full Text] [Related]
20. Matched sibling donor stem cell transplantation for Fanconi anemia patients with T-cell somatic mosaicism.
Yabe M; Shimizu T; Morimoto T; Koike T; Takakura H; Tsukamoto H; Muroi K; Oshima K; Asami K; Takata M; Yamashita T; Kato S; Yabe H
Pediatr Transplant; 2012 Jun; 16(4):340-5. PubMed ID: 22404423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
